Circulating Tumor Cells Market: Monitoring, Profiling and the Regulatory Landscape
The circulating tumor cells market was valued at USD 14.15 billion in 2025 and is forecast to reach USD 45.13 billion by 2034, expanding at a CAGR of 13.8% from 2026 to 2034, with a 2026 estimate of USD 16.08 billion. Beyond the headline values, B2B buyers need to understand how CTC testing compares with other circulating biomarkers, where it is applied clinically, and how it is regulated. This...
0 Comentários 0 Compartilhamentos 30 Visualizações